🇺🇸 Trinitrin in United States
114 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 114
Most-reported reactions
- Drug Interaction — 15 reports (13.16%)
- Asphyxia — 14 reports (12.28%)
- Intra-Abdominal Haemorrhage — 13 reports (11.4%)
- Overdose — 13 reports (11.4%)
- Hypoglycaemia — 11 reports (9.65%)
- Blood Urine Present — 10 reports (8.77%)
- Laryngeal Haematoma — 10 reports (8.77%)
- Upper Airway Obstruction — 10 reports (8.77%)
- Drug Level Increased — 9 reports (7.89%)
- Ecchymosis — 9 reports (7.89%)
Other Other approved in United States
Frequently asked questions
Is Trinitrin approved in United States?
Trinitrin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Trinitrin in United States?
Assistance Publique - Hôpitaux de Paris is the originator. The local marketing authorisation holder may differ — check the official source linked above.